跳至主要内容
临床试验/ITMCTR2000003135
ITMCTR2000003135尚未招募1 期

Study on the effect of Jiangtangxiaozhi Capsule on the intestinal flora of obese IGT patients by the determination of LPS and GLP-1

Xiyuan Hospital,China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 60(—)
性别
All

入选标准

  • 1. Aged 18-60 years old;
  • 2. IGT and obesity diagnostic criteria were met;
  • 3. No antibiotics, probiotics and any other Chinese and Western medicine for digestive system diseases were used within 1 month before treatment;
  • 4. There was no history of chronic gastrointestinal disease and hepatobiliary infection;
  • 5. Signed informed consent.

排除标准

  • 1. ALT and AST were 1.5 times higher than the upper limit of normal value and creatinine was higher than the upper limit of normal value;
  • 2. TG>5.7mmol/l;
  • 3. Patients with severe circulatory system diseases, respiratory system diseases, immune system diseases, malignant tumors and other serious diseases;
  • 4. Those who have obvious diet preference or single diet habit;
  • 5. Those who take metformin, acarbose and other Western medicine and have the effect of reducing blood sugar;
  • 6. Participants in other clinical trials within 3 months;
  • 7. Mental illness patients;
  • 8. Pregnant or lactating women;
  • 9. Those who are intolerant to jiangtangxiaozhi capsule or simulant.

研究者

相似试验